Valneva SE VALN
NASDAQ VALN
$7.00 -0.06 (-0.85%)
As of: Sep 4, 2026 · 1:38 PM EDT

Valneva SE (VALN) Research & Development (2021 - 2026)

Valneva SE (VALN) posted Research & Development of -$17.8 million for Q1 2026, down 110.55% sequentially from $168.8 million in Q4 2025, and down 13.25% YoY from -$20.5 million in Q1 2025.

Analysis

Valneva SE (VALN) Research & Development (2021 - 2026) Analysis & Trends

Valneva SE has reported Research & Development for 6 years, with the latest figure at -$17.8 million in Q1 2026.

  • Quarterly Research & Development fell 13.25% year-over-year to -$17.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $99.3 million (up 29.26% YoY) and the FY2025 annual result came in at $99.3 million, up 23.74% from the prior year.
  • Research & Development slipped to -$17.8 million in Q1 2026 per VALN's latest filing, from $168.8 million in the prior quarter.
  • Over five years, Research & Development peaked at $184.0 million in Q4 2022 and troughed at -$33.3 million in Q2 2022.
  • A 5-year average of $19.4 million and a median of -$17.7 million in 2023 frame the typical range for Research & Development.
  • The sharpest annual moves came in 2023 and 2025: Research & Development jumped 61.03% in 2023, then tumbled 53.82% in 2025.
  • Over 5 years, Research & Development stood at $184.0 million in 2022, then sank by 40.28% to $109.9 million in 2023, then climbed by 19.35% to $131.1 million in 2024, then climbed by 28.75% to $168.8 million in 2025, then slumped by 110.55% to -$17.8 million in 2026.
  • According to Business Quant data, Research & Development over the past three periods registered -$17.8 million, $168.8 million, and -$31.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn 993.80 Mn
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 1.63 Bn
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -486.00 Mn
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn 651.00 Mn
5 Revolution Medicines 44.07 Bn 44.07 Bn - 394.92 Mn
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 612.28 Mn
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn 413.13 Mn
8 Royalty Pharma 28.42 Bn 27.58 Bn - 97.90 Mn
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 210.03 Mn
10 Valneva SE 588.63 Mn 447.37 Mn 1.86 Mn -17.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.46 Mn
Mar 31, 2026 -17.81 Mn
Dec 31, 2025 -29.77 Mn
Sep 30, 2025 -31.90 Mn
Jun 30, 2025 -19.80 Mn
Mar 31, 2025 -15.73 Mn
Dec 31, 2024 -27.33 Mn
Sep 30, 2024 -20.74 Mn
Jun 30, 2024 -17.82 Mn
Mar 31, 2024 -14.27 Mn
Dec 31, 2023 -19.02 Mn
Sep 30, 2023 -17.68 Mn
Jun 30, 2023 -12.97 Mn
Mar 31, 2023 -15.10 Mn
Dec 31, 2022 -30.14 Mn
Sep 30, 2022 -23.70 Mn
Jun 30, 2022 -33.29 Mn
Mar 31, 2022 -23.22 Mn
Dec 31, 2021 -64.12 Mn
Sep 30, 2021 -45.40 Mn